冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - allopurinolum inn - tafla - 100 mg

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - allopurinolum inn - tafla - 300 mg

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

orion corporation - methotrexatum inn - tafla - 2,5 mg

欧盟 - 冰岛文 - EMA (European Medicines Agency)

viatris limited - tadalafil - háþrýstingur, lungnabólga - Þvaglát - talmanco er ætlað í fullorðnir fyrir meðferð lungum slagæð háan blóðþrýsting (pah) flokkast sem hagnýtur ii og iii, til að bæta æfing getu. verkun hefur verið sýnd í sjálfvakta pah (ipah) og í pah í tengslum við krabbameinsvaldandi sjúkdóma.

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

krka, d.d., novo mesto - clarithromycinum inn - filmuhúðuð tafla - 250 mg

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

krka, d.d., novo mesto - clarithromycinum inn - filmuhúðuð tafla - 500 mg

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - clarithromycinum inn - filmuhúðuð tafla - 500 mg

欧盟 - 冰岛文 - EMA (European Medicines Agency)

astrazeneca ab - acalabrutinib - kyrningahvítblæði, eitilfrumnafæð, langvarandi, b-frumur - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

krka sverige ab - lansoprazolum inn - magasýruþolið hart hylki - 30 mg

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

krka sverige ab - lansoprazolum inn - magasýruþolið hart hylki - 15 mg